The 3rd Precision Medicine in Inflammatory Bowel Disease covers topics such as:
- Discovering Functional Biomarkers to Identify Combination Therapies for Subtype-Driven Drug Development
- Overcome IBD Heterogeneity with Novel Biomarkers for Better Patient Stratification
- Expedite Microbiome Profiling to Refine Treatment Options with Better Biomarkers for IBD
- Better Biomarkers for Clinical Monitoring to Effectively Manage & Treat Patients in Need
- Enhancing Safety & Efficacy to Accelerate Patient Access to Personalized Drugs
- Novel Approaches to Deliver Best-In-Class IBD Drugs to Patients in Need
The 3rd Precision Medicine in Inflammatory Bowel Disease might be held in Boston, United States in 2025.
